RXL ProShares Ultra Health Care

USD 93.22 0.60 0.645957
Icon

ProShares Ultra Health Care (RXL) Stock Analysis and Price Targets

ETF | Trading--Leveraged Equity | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 93.22

+0.60 (+0.65)%

USD 0.09B

2.84K

N/A

N/A

Icon

RXL

ProShares Ultra Health Care (USD)
ETF | NYE
USD 93.22
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.09B

N/A

USD 93.22

ProShares Ultra Health Care (RXL) Stock Forecast

N/A

Based on the ProShares Ultra Health Care stock forecast from 0 analysts, the average analyst target price for ProShares Ultra Health Care is not available over the next 12 months. ProShares Ultra Health Care’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ProShares Ultra Health Care is Bullish , which is based on 5 positive signals and 1 negative signals. At the last closing, ProShares Ultra Health Care’s stock price was USD 93.22. ProShares Ultra Health Care’s stock price has changed by -0.03% over the past week, -10.08% over the past month and +2.22% over the last year.

No recent analyst target price found for ProShares Ultra Health Care
No recent average analyst rating found for ProShares Ultra Health Care

Company Overview ProShares Ultra Health Care

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health...Read More

http://www.proshares.com

13, Boulevard du Fort de Vaux, Paris, France, 75838

26,537

December

USD

USA

30/01/2007

DJ US Health Care TR USD

S&P 500 TR USD

0.95 %

Adjusted Closing Price for ProShares Ultra Health Care (RXL)

Loading...

Unadjusted Closing Price for ProShares Ultra Health Care (RXL)

Loading...

Share Trading Volume for ProShares Ultra Health Care Shares

Loading...

Compare Performance of ProShares Ultra Health Care Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for RXL

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • 1

  • S&P 500 TR USD

  • 4

  • 29.06

  • 0.00

  • 0.38

  • 6.68%

  • 6.46%

  • 13.51%

  • 0%

Stocks Similar To ProShares Ultra Health Care (Sector: Trading--Leveraged Equity )

Symbol Name Mer Price(Change) Market Cap
SOXL
Direxion Daily Semiconductor B.. 0.76 % -4.12 (-11.80%) USD10.94B

ETFs Containing RXL

Symbol Name RXL's Weight Expense Ratio Price(Change) Market Cap
SMCX:SW
SPDR® MSCI Europe Small .. 0.49 % 0.00 % -3.20 (-1.12%) USD0.22B

Frequently Asked Questions About ProShares Ultra Health Care (RXL) Stock

Stock Target Advisor's fundamental analysis for ProShares Ultra Health Care's stock is Bullish .

RXL stock's dividend yield is 0.32%. Our analysis grades RXL stock's dividend yield at F. This means that RXL stock's dividend yield is above 16% of the stocks in the Trading--Leveraged Equity sector in the NYE exchange. Based on this RXL may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on RXL's stock to indicate what its average analyst target is.

RXL stock's Price/Earning ratio is 7.43. Our analysis grades RXL stock's Price / Earning ratio at A+. This means that RXL stock's Price/Earning ratio is above 2.000000000000002% of the stocks in the Trading--Leveraged Equity sector in the NYE exchange. Based on this RXL may be undervalued for its sector.

The last closing price of RXL's stock was USD 93.22.

The most recent market capitalization for RXL is USD 0.09B.

Unfortunately we do not have enough analyst data on RXL's stock to indicate whether its price will go up or not.

Following are ETFs with the highest allocation to ProShares Ultra Health Care's stock :

SMCX:SW

As per our most recent records ProShares Ultra Health Care has 26,537 Employees.

ProShares Ultra Health Care's registered address is 13, Boulevard du Fort de Vaux, Paris, France, 75838. You can get more information about it from ProShares Ultra Health Care's website at http://www.proshares.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...